Xinlan Lu
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Gastroenterology top 10%
Papers in ⓘ
-
- Circular RNAs in diseases 8
- Ubiquitin and proteasome pathways 4
- RNA modifications and cancer 3
-
- MicroRNA in disease regulation 9
- Cancer-related molecular mechanisms research 7
- Co-authors
- Mudan Ren (22 shared papers)Shuixiang He (15 shared papers)Yarui Li (13 shared papers)Guifang Lu (10 shared papers)Yan Zhao (13 shared papers)Guifang Lu (12 shared papers)Dan Guo (6 shared papers)Dan Zhang (8 shared papers)
- Journals
- Oncology Reports (3 papers)Cell Death and Disease (2 papers)Journal of Gastroenterology and Hepatology (2 papers)Digestive Diseases and Sciences (2 papers)Scandinavian Journal of Gastroenterology (2 papers)
- Partner nations
- ChinaAustraliaBangladesh
In The Last Decade
Xinlan Lu
38 papers receiving 781 citations
Peers
Comparison fields: 5 of 78
- Cancer Research 368
- Gastroenterology 49
- Toxicology 28
- Molecular Biology 487
- Complementary and alternative medicine 37
Countries citing papers authored by Xinlan Lu
This map shows the geographic impact of Xinlan Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinlan Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinlan Lu more than expected).
Fields of papers citing papers by Xinlan Lu
This network shows the impact of papers produced by Xinlan Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinlan Lu. The network helps show where Xinlan Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xinlan Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 109 | |
| 2 | 2019 | 68 | |
| 3 | 2012 | 53 | |
| 4 | 2019 | 47 | |
| 5 | 2016 | 42 | |
| 6 | 2017 | 41 | |
| 7 | 2020 | 40 | |
| 8 | 2014 | 33 | |
| 9 | 2015 | 31 | |
| 10 | 2018 | 29 | |
| 11 | 2020 | 28 | |
| 12 | 2018 | 27 | |
| 13 | 2020 | 26 | |
| 14 | 2018 | 25 | |
| 15 | 2018 | 22 | |
| 16 | 2013 | 19 | |
| 17 | 2022 | 17 | |
| 18 | Sinomenine reverses multidrug resistance in bladder cancer cells via P-glycoprotein-dependent and independent manners. | 2014 | 16 |
| 19 | 2020 | 15 | |
| 20 | 2017 | 15 |
About Xinlan Lu
Xinlan Lu is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Surgery and Oncology, having authored 40 papers that have together received 790 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (9 papers), Gastric Cancer Management and Outcomes (9 papers), Circular RNAs in diseases (8 papers), Cancer-related molecular mechanisms research (7 papers), Helicobacter pylori-related gastroenterology studies (4 papers), Ubiquitin and proteasome pathways (4 papers), Gastrointestinal Tumor Research and Treatment (3 papers) and RNA modifications and cancer (3 papers). The work is most often cited by research in Cancer Research (368 citations), Gastroenterology (49 citations), Toxicology (28 citations), Molecular Biology (487 citations) and Complementary and alternative medicine (37 citations). Xinlan Lu has collaborated with scholars based in China, Australia and Bangladesh. Frequent co-authors include Mudan Ren, Shuixiang He, Yarui Li, Guifang Lu, Yan Zhao, Guifang Lu, Dan Guo, Dan Zhang, Xin Wang and Shuixiang He. Their work appears in journals such as Oncology Reports, Cell Death and Disease, Journal of Gastroenterology and Hepatology, Digestive Diseases and Sciences and Scandinavian Journal of Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.